GSK (LON:GSK) Rating Reiterated by Citigroup

Citigroup reissued their buy rating on shares of GSK (LON:GSK) in a research report sent to investors on Monday morning, MarketBeat.com reports. They currently have a GBX 2,100 ($26.64) target price on the stock.

Several other analysts have also issued reports on GSK. JPMorgan Chase & Co. reiterated an underweight rating on shares of GSK in a report on Tuesday, June 18th. Barclays reiterated an equal weight rating and set a GBX 1,725 ($21.88) target price on shares of GSK in a report on Tuesday, May 7th. Shore Capital reiterated a buy rating on shares of GSK in a report on Wednesday, June 12th. Finally, Deutsche Bank Aktiengesellschaft reiterated a buy rating and set a GBX 1,950 ($24.74) target price on shares of GSK in a report on Tuesday, June 18th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of Moderate Buy and a consensus price target of GBX 1,791.25 ($22.72).

GSK Stock Down 4.6 %

GSK stock opened at GBX 1,526 ($19.36) on Monday. The company has a debt-to-equity ratio of 134.34, a current ratio of 0.87 and a quick ratio of 0.73. The stock has a market capitalization of £62.26 billion, a P/E ratio of 1,400.00, a P/E/G ratio of 1.19 and a beta of 0.27. The business has a 50-day moving average of GBX 1,688.38 and a 200-day moving average of GBX 1,629.94. GSK has a fifty-two week low of GBX 1,302.60 ($16.52) and a fifty-two week high of GBX 1,823.50 ($23.13).

GSK Cuts Dividend

The company also recently announced a dividend, which will be paid on Thursday, July 11th. Stockholders of record on Thursday, May 16th will be paid a dividend of GBX 15 ($0.19) per share. The ex-dividend date of this dividend is Thursday, May 16th. This represents a dividend yield of 0.9%. GSK’s dividend payout ratio (DPR) is currently 5,504.59%.

Insider Transactions at GSK

In other news, insider Wendy Becker bought 446 shares of the stock in a transaction dated Thursday, June 20th. The shares were bought at an average price of GBX 1,614 ($20.47) per share, for a total transaction of £7,198.44 ($9,131.60). 1.60% of the stock is owned by corporate insiders.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.